Despite the limited number of PBMCs and liver samples tested, we confirmed that our panel was able to identify described peripheral and liver (tr-NK and c-NK) NK cells, lt-ILC1s and clusters prevalent in the liver of HCC donors A key improvement that was made in this panel is the inclusion of CD94, HLA-DR and CD127. The gene discussed is KLRD1; the disease is hepatocellular carcinoma.